These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11897405)

  • 21. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
    Sintov AC; Levy HV; Botner S
    J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
    Bae HD; Lee K
    J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits.
    Najafabadi AR; Moslemi P; Tajerzadeh H
    Drug Deliv; 2004; 11(5):295-300. PubMed ID: 15742554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic considerations of new insulin formulations and routes of administration.
    Hoffman A; Ziv E
    Clin Pharmacokinet; 1997 Oct; 33(4):285-301. PubMed ID: 9342504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition.
    Podder SK; Moy KC; Lee VH
    Exp Eye Res; 1992 May; 54(5):747-57. PubMed ID: 1623960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
    Pfützner A; Forst T
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
    Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
    J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic delivery of insulin via an enhancer-free ocular device.
    Lee YC; Simamora P; Yalkowsky SH
    J Pharm Sci; 1997 Dec; 86(12):1361-4. PubMed ID: 9423146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular device for the controlled systemic delivery of insulin.
    Simamora P; Lee YC; Yalkowsky SH
    J Pharm Sci; 1996 Oct; 85(10):1128-30. PubMed ID: 8897284
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent Advancemnts in Biodegradable Ocular Implants.
    Mittal S; Miranda O
    Curr Drug Deliv; 2018 Feb; 15(2):144-154. PubMed ID: 28482784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
    Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DS-1, a modified Quillaja saponin, enhances ocular and nasal absorption of insulin.
    Pillion DJ; Recchia J; Wang P; Marciani DJ; Kensil CR
    J Pharm Sci; 1995 Nov; 84(11):1276-9. PubMed ID: 8587042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimizing systemic absorption of topically administered ophthalmic drugs.
    Urtti A; Salminen L
    Surv Ophthalmol; 1993; 37(6):435-56. PubMed ID: 8100087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DDS for insulin--development of non-injection dosage forms].
    Murakami M; Muranishi S
    Nihon Rinsho; 1997 Nov; 55 Suppl():273-81. PubMed ID: 9434480
    [No Abstract]   [Full Text] [Related]  

  • 36. Solid lipid nanoparticles for pulmonary delivery of insulin.
    Liu J; Gong T; Fu H; Wang C; Wang X; Chen Q; Zhang Q; He Q; Zhang Z
    Int J Pharm; 2008 May; 356(1-2):333-44. PubMed ID: 18281169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug delivery system for diabetes].
    Yamasaki Y
    Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
    Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
    Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of therapeutics for deep-seated ocular conditions - status quo.
    Nguyen H; Eng S; Ngo T; Dass CR
    J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
    Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
    Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.